Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;92(6):499-505.
doi: 10.1007/s00104-021-01355-3. Epub 2021 Feb 10.

[Neoadjuvant and perioperative treatment of gastric cancer, current studies and new biomarkers]

[Article in German]
G Stocker  1   2 , R Thieme  3 , F Lordick  4   5
Affiliations
Review

[Neoadjuvant and perioperative treatment of gastric cancer, current studies and new biomarkers]

[Article in German]
G Stocker et al. Chirurg. 2021 Jun.

Abstract
in English, German

According to current German and European clinical practice guidelines perioperative chemotherapy is the recommended standard of care for localized gastric cancer beyond early cancers, i.e. in stage IB (T2 N0 M0 and T1 N1 M0) or greater. For patients who are able to tolerate intensive chemotherapy, the FLOT regimen (5-fluorouracil, folinic acid, oxaliplatin, docetaxel) should be administered preoperatively and postoperatively for four cycles each. Locally advanced nonmetastatic adenocarcinoma of the esophagogastric junction (AEG) should be treated with perioperative chemotherapy as for gastric cancer or alternatively with neoadjuvant chemoradiotherapy. The best approach for AEG is currently being investigated in ongoing clinical trials. The recommendation of perioperative treatment applies to all histopathological subtypes of gastric cancer. The article summarizes the contemporary data and provides an outlook on current progress in the field of medicinal perioperative treatment.

Perioperative Chemotherapie ist nach aktuellen deutschen und europäischen Therapieleitlinien empfohlener Standard bei lokalisierten Magenkarzinomen jenseits der Frühkarzinome, also ab Stadium IB (T2 N0 M0 und T1 N1 M0). Für Patienten, die eine intensive Chemotherapie tolerieren, werden je 4 Zyklen des FLOT-Regimes (5-Fluorouracil, Folinsäure Oxaliplatin, Docetaxel) prä- und postoperativ empfohlen. Lokal fortgeschrittene, nicht fernmetastasierte Adenokarzinome des ösophagogastralen Übergangs (AEG) sollen wie Magenkarzinome mit einer perioperativen Chemotherapie behandelt werden oder alternativ mit einer neoadjuvanten Radiochemotherapie. Laufende Studien klären die Frage nach dem zu favorisierenden Vorgehen bei AEGs. Die Empfehlung einer perioperativen Therapie gilt für alle histopathologischen Subtypen des Magenkarzinoms. Der Beitrag fasst die aktuelle Datenlage zusammen und gibt einen Ausblick auf aktuelle Entwicklungen auf dem Gebiet der medikamentösen perioperativen Therapie.

Keywords: Adenocarcinoma of the esophagogastric junction; Chemotherapy; FLOT regimen; Neoadjuvant chemoradiotherapy; Treatment guidelines.

PubMed Disclaimer

References

Literatur

    1. Al-Batran S‑E, Schuler MH, Zvirbule Z et al (2016) FAST: An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody, as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma. J Clin Oncol. https://doi.org/10.1200/JCO.2016.34.18_suppl.LBA4001 - DOI - PubMed
    1. Al-Batran S, Haag GM, Ettrich TJ et al (2020) 1421MO – final results and subgroup analysis of the PETRARCA randomized phase II AIO trial: perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma. Ann Oncol 31:S899 - DOI
    1. Al-Batran SE, Homann N, Pauligk C et al (2019) Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393:1948–1957 - DOI
    1. An JY, Kim H, Cheong JH et al (2012) Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5‑FU based chemotherapy after R0 resection. Int J Cancer 131:505–511 - DOI
    1. Bang YJ, Van Cutsem E, Feyereislova A et al (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687–697 - DOI

MeSH terms

LinkOut - more resources